JiuZhou Pharma Retains EcoVadis Gold Rating, Ranking Among the Top 5% Globally


Release time:

2026-03-09

Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.

EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.

In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.

Other News

Peptide API Manufacturing Enters a New Era of Innovation and Global Expansion

Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.

EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.

In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.

2026-04-16

JiuZhou Pharma Selected for S&P Global’s Sustainability Yearbook (China Edition) 2026

Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.

EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.

In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.

2026-04-14

Topical Formulation CDMO Gains Momentum as Demand for Advanced Drug Delivery Surges

Recently, JiuZhou Pharma was once again awarded the EcoVadis Gold Rating. This marks the third consecutive year that JiuZhou Pharma has participated in the EcoVadis assessment at the group level, and the second consecutive year the company has achieved the prestigious Gold rating.

EcoVadis is a leading global sustainability rating platform that evaluates companies across four key areas: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. As more customers establish stringent ESG standards in their supplier selection processes, ratings such as EcoVadis have increasingly become an important factor in decision-making.

In the latest assessment, JiuZhou Pharma once again ranked among the top 5% of companies globally. This strong EcoVadis rating not only demonstrates to our customers, partners, and investors that we take sustainability seriously, but also reflects JiuZhou Pharma’s globally leading performance in environmental, social, and governance (ESG) management.

2026-04-09

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us

Jiuzhou

LinkedIn

License

Powered by 300.cn

Business Collaboration

Innovative Drug CDMO Services

Established Business Services(API)

Human Resources

Join Us




[Multiple]Interested business area:
Small Molecule CDMO Services
CDMO-Preparations
CDMO-Polypeptide
Generic drug Service
Registration & Regulatory Service
Animal Health Services